Study of a novel hypervariable region in hepatitis C virus (HCV) E2 envelope glycoprotein

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Hepatitis C virus (HCV) exhibits significant sequence variation, primarily in the E2 envelope glycoprotein's N-terminal hypervariable regions (HVR1 and HVR2).
• Understanding HCV variability is crucial for developing effective antiviral strategies and vaccines.

Purpose of the Study:

• To identify and characterize novel hypervariable regions within the HCV E2 envelope glycoprotein.
• To investigate the functional significance of these regions in viral evolution and pathogenesis.

Main Methods:

• Analysis of 391 E2 sequences from 17 HCV-infected subjects using amino acid entropy.
• Genetic distance analysis to delineate subdomains within identified regions.
• Examination of synonymous and nonsynonymous nucleotide substitutions.
• Physicochemical and antigenicity predictions, residue conservation analysis, and molecular modeling.

Main Results:

• A third hypervariable region (HVR3, residues 431-466) was identified in the E2 glycoprotein, distinct from HVR1 and HVR2.
• HVR3 was further subdivided into three distinct subdomains: HVR3a, HVR3b, and HVR3c.
• Strong intrahost selective pressure was observed in the HVR3a subdomain.
• Computational analyses supported the proposed organization and functional relevance of HVR3.

Conclusions:

• The discovery of HVR3 adds to the understanding of HCV sequence variability.
• HVR3 likely contributes to viral entry and host-receptor interactions, similar to HVR1 and HVR2.
• Further research into HVR3 may reveal new therapeutic targets for HCV infection.